Dysmenorrhea

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2016-09-13
FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.)
FDA Approved: CELECOXIB — Supplemental Application (Cipla USA Inc.) indicating a labeling modification related to celecoxib.